TCG Crossover GP I LLC 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:24 pm Sale | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | TCG Crossover GP I LLC | 2,912,861 1.600% | -8,198,250 (-73.78%) | Filing |
| 2023-08-25 4:22 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | TCG Crossover GP I LLC | 11,111,111 5.900% | 11,111,111 (New Position) | Filing |